| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 359.5 | 272.4 |
| Net income | 51.7 | -39.6 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +32.0% |
|---|
6-K filed with the SEC, NASDAQ: LEGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Legend Biotech Corp: key numbers
- Share price
- $15.99Close, Nov 16
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Legend Biotech Corp
All →Legend Biotech Director Corazon (Corsee) D. Sanders Sells $259K of Stock
Corazon (Corsee) D. Sanders, Director, sold 27,370 shares of Legend Biotech Corp at $9.46 a share, worth $259K in total on Sep 29, 2026. Shares held after the trade: 52,731 (-34.2%).
- Value
- $259K
- Shares
- 27,370
- Price
- $9.46
- Role
- Director
- Holding change
- -34.2%
- Trade date
- Sep 29, 2026